What are the characteristics of Staphylococcus aureus pneumonia?

Staphylococcus aureus pneumonia is a serious, often rapidly progressive bacterial pneumonia that predominantly affects vulnerable populations—including infants, the elderly, immunocompromised individuals, and patients recovering from influenza or other viral respiratory infections. It is characterized by its aggressive clinical course, high potential for complications, and propensity to cause necrotizing lung injury.

Clinically, patients typically present with acute onset of high fever, chills, productive cough (often with purulent or blood-tinged sputum), tachypnea, and pleuritic chest pain. Unlike typical community-acquired pneumonia, S. aureus pneumonia may progress rapidly over hours to days, with signs of systemic toxicity such as leukocytosis, hypotension, and respiratory distress. In post-influenza cases, deterioration often occurs 3–5 days after initial viral symptom improvement—a red flag for secondary bacterial infection.

Radiographically, findings are variable but frequently include multilobar infiltrates, cavitation, pneumatoceles (thin-walled, air-filled cysts—especially common in children), and pleural effusions. Pneumatoceles may persist for weeks and can predispose to complications such as rupture leading to pneumothorax or secondary infection. Empyema and lung abscess formation are also well-documented complications.

Diagnosis relies on microbiologic confirmation: isolation of S. aureus from blood cultures, sputum (ideally with quantitative culture and Gram stain showing gram-positive cocci in clusters), or bronchoalveolar lavage fluid. Given the increasing prevalence of methicillin-resistant S. aureus (MRSA), empiric antibiotic therapy must cover MRSA—typically with intravenous vancomycin, linezolid, or clindamycin (depending on local susceptibility patterns and clinical context)—while awaiting culture results. Definitive therapy should be tailored based on antimicrobial susceptibility testing.

Management extends beyond antibiotics and requires vigilant supportive care: supplemental oxygen, mechanical ventilation if indicated, drainage of empyema or abscesses when appropriate, and close monitoring for sepsis and multiorgan dysfunction. Mortality remains significant—particularly in ICU-admitted or immunocompromised patients—underscoring the importance of early recognition and aggressive intervention.